Cargando…
Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer
Globally, bladder cancer (BC) is one of the ten most common tumors. Obesity is a worldwide problem associated with an increased BC risk. Considering that levels of leptin and/or its receptor are often deregulated in obese individuals, we hypothesized that they could contribute to BC. To test this hy...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604959/ https://www.ncbi.nlm.nih.gov/pubmed/37892180 http://dx.doi.org/10.3390/biom13101498 |
_version_ | 1785126959375712256 |
---|---|
author | Alfaqih, Mahmoud A. Elsalem, Lina Nusier, Mohamad Mhedat, Khawla Khader, Yousef Ababneh, Ebaa |
author_facet | Alfaqih, Mahmoud A. Elsalem, Lina Nusier, Mohamad Mhedat, Khawla Khader, Yousef Ababneh, Ebaa |
author_sort | Alfaqih, Mahmoud A. |
collection | PubMed |
description | Globally, bladder cancer (BC) is one of the ten most common tumors. Obesity is a worldwide problem associated with an increased BC risk. Considering that levels of leptin and/or its receptor are often deregulated in obese individuals, we hypothesized that they could contribute to BC. To test this hypothesis, we utilized a case-control study in which 116 patients with a confirmed diagnosis of BC and 116 controls were recruited. The serum levels of leptin and leptin receptor were measured. Patients and controls were also genotyped for SNPs in the LEP (rs7799039, rs791620, and rs2167270) and LEPR genes (rs1137100, rs1137101, and rs1805094). The univariate analysis indicated that BC patients had significantly higher levels of leptin and lower levels of leptin receptor (p < 0.05). Moreover, rs7799039 of LEP and rs1137101 of LEPR were associated with BC (p < 0.05). In the multivariate analysis, leptin receptor levels were protective (OR: 0.98, 95% CI = 0.97–0.99, p = 0.002) while the GG genotype of rs1137101 of LEPR increased BC risk (OR: 3.42, 95% CI = 1.27–9.20, p = 0.02). These findings highlight that lifestyle changes could be useful in preventing BC and that disturbances in energy metabolism could play a role in the pathobiology of BC. |
format | Online Article Text |
id | pubmed-10604959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106049592023-10-28 Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer Alfaqih, Mahmoud A. Elsalem, Lina Nusier, Mohamad Mhedat, Khawla Khader, Yousef Ababneh, Ebaa Biomolecules Article Globally, bladder cancer (BC) is one of the ten most common tumors. Obesity is a worldwide problem associated with an increased BC risk. Considering that levels of leptin and/or its receptor are often deregulated in obese individuals, we hypothesized that they could contribute to BC. To test this hypothesis, we utilized a case-control study in which 116 patients with a confirmed diagnosis of BC and 116 controls were recruited. The serum levels of leptin and leptin receptor were measured. Patients and controls were also genotyped for SNPs in the LEP (rs7799039, rs791620, and rs2167270) and LEPR genes (rs1137100, rs1137101, and rs1805094). The univariate analysis indicated that BC patients had significantly higher levels of leptin and lower levels of leptin receptor (p < 0.05). Moreover, rs7799039 of LEP and rs1137101 of LEPR were associated with BC (p < 0.05). In the multivariate analysis, leptin receptor levels were protective (OR: 0.98, 95% CI = 0.97–0.99, p = 0.002) while the GG genotype of rs1137101 of LEPR increased BC risk (OR: 3.42, 95% CI = 1.27–9.20, p = 0.02). These findings highlight that lifestyle changes could be useful in preventing BC and that disturbances in energy metabolism could play a role in the pathobiology of BC. MDPI 2023-10-09 /pmc/articles/PMC10604959/ /pubmed/37892180 http://dx.doi.org/10.3390/biom13101498 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alfaqih, Mahmoud A. Elsalem, Lina Nusier, Mohamad Mhedat, Khawla Khader, Yousef Ababneh, Ebaa Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title | Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title_full | Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title_fullStr | Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title_full_unstemmed | Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title_short | Serum Leptin Receptor and the rs1137101 Variant of the LEPR Gene Are Associated with Bladder Cancer |
title_sort | serum leptin receptor and the rs1137101 variant of the lepr gene are associated with bladder cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604959/ https://www.ncbi.nlm.nih.gov/pubmed/37892180 http://dx.doi.org/10.3390/biom13101498 |
work_keys_str_mv | AT alfaqihmahmouda serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer AT elsalemlina serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer AT nusiermohamad serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer AT mhedatkhawla serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer AT khaderyousef serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer AT ababnehebaa serumleptinreceptorandthers1137101variantoftheleprgeneareassociatedwithbladdercancer |